Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists [0.03%]
药学临床药师改善患者医疗服务接入和门诊使用的营销影响
Nora Bairagdar,Ashley Reich,Jessica Bovio Franck
Nora Bairagdar
Introduction: This quality improvement initiative aimed to implement a strategy to increase access to care with clinical pharmacy specialists (CPSs), optimize CPS direct patient care activities, and promote clinical pharm...
Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription [0.03%]
住院接受精神疾病治疗且持有居家阿片类药物处方患者的入院诊疗特征分析
Kei Takamura,Amy M Hebbard,Sophie Robert
Kei Takamura
Introduction: Patients with mental illness are particularly at risk for OUD, and due to this higher risk, providers may be more inclined to withhold their home opioids when they are admitted to a psychiatric hospital. Pat...
Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population [0.03%]
住院青少年兴奋剂药物持有对其躁动的影响研究
Anupha M Mathew,Sophie Robert,Clint Ross et al.
Anupha M Mathew et al.
Introduction: This study aimed to compare the rates of agitation-related interventions associated with initial holding versus continuation of home stimulant(s) in a child and adolescent population at the time of admission...
Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents [0.03%]
评估低剂量哌唑嗪对儿童和青少年PTSD相关噩梦的效果
Nancy Hudson,Steven Burghart,Jill Reynoldson et al.
Nancy Hudson et al.
Introduction: Knowledge about fundamental sleep disorders and dysregulation that occurs in children with PTSD is limited. Prazosin is an alpha-1 receptor antagonist often used off label for the treatment of PTSD-associate...
Evaluation of the use of chlorpromazine for agitation in pediatric patients [0.03%]
评价氯丙嗪用于儿科患者的抗焦虑和躁动状态的研究
Rajwoana Ahmed,Megan Maroney,Germin Fahim et al.
Rajwoana Ahmed et al.
Introduction: Chlorpromazine is a first-generation antipsychotic used for behavioral problems in pediatric patients. However, other therapies may demonstrate both improved outcomes and fewer side effects. Within our insti...
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone [0.03%]
阿片类药物使用障碍布普品丙稀/纳洛酮的提供和管理中的医师-药师协作实践模型的发展与实施
Lindsay M Mailloux,Matthew T Haas,Janel M Larew et al.
Lindsay M Mailloux et al.
Introduction: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality imp...
Megan O&#x;Connell,Elizabeth Hunt,Amy VandenBerg
Megan O&#x;Connell
Objective: To describe a case of a patient who developed psychosis after ingestion of Vertigoheel for treatment of dizziness. Case summary: ...
Undetectable serum lithium concentrations after coadministration of liquid lithium citrate and apple juice: A case report [0.03%]
柠檬酸锂液和苹果汁合用后检测不到血清锂浓度：病例报告
Sundus Awan,Audrey Abelleira,Loveleen Khehra et al.
Sundus Awan et al.
Lithium is a mood-stabilizing medication approved by the FDA for the treatment of acute manic or mixed episodes of bipolar disorder as well as maintenance treatment. Lithium citrate is an oral solution, and the carbonate salt is available a...
Successful bilateral electroconvulsive therapy in a patient with a seizure disorder taking levetiracetam, lorazepam, and zonisamide: A case report [0.03%]
成功接受双侧电休克治疗的病例报告：左乙拉西坦、劳拉西泮和佐噪胺联合治疗难治性癫痫发作患者
Ian R McGrane,Rachel E Tenison,Dana M Bimler et al.
Ian R McGrane et al.
Electroconvulsive therapy (ECT) may be considered for treatment of severe, treatment-resistant, and emergent depression associated with MDD or bipolar disorder. Patients with epilepsy usually take medications that raise the seizure threshol...
Rifampin-divalproex drug-drug interaction in an adult patient: A case report [0.03%]
异烟肼和双丙戊酸钠相互作用导致成人患者肝衰竭：一例报告
Christine Doran,Michael Moro,Jennifer Green et al.
Christine Doran et al.
The divalproex (DVP) package insert states that rifampin may increase the oral clearance of valproate by 40% and that valproic acid derivative dose adjustments may be required when starting or stopping rifampin. However, the overall clinica...